Srinivasan Neil T, Segal Oliver R
The Heart Hospital, University College Hospital, London, UK.
Institute of Cardiovascular Sciences, UCL, London, UK.
J Cardiol Cases. 2015 Aug 29;12(6):180-182. doi: 10.1016/j.jccase.2015.08.004. eCollection 2015 Dec.
A 49-year-old man was admitted with symptomatic, sustained monomorphic ventricular tachycardia. He had a previous history of AMP-kinase disease associated with hypertrophic cardiomyopathy and complete heart block, and a pre-existing dual chamber pacemaker. He also had a mechanical tricuspid valve replacement and mitral valve replacement, for severe tricuspid regurgitation from right ventricle (RV) lead-induced injury to the tricuspid valve and a fibroblastoma on the mitral valve. His pre-existing RV lead was maintained between the prosthetic valve annulus and the native annulus. Inability to place an implantable cardioverter-defibrillator (ICD) in the RV due to the presence of a mechanical tricuspid valve replacement represented a rare but challenging clinical scenario. Surgical epicardial lead placement or the use of a subcutaneous ICD (S-ICD) were possible alternatives. Traditional ICD lead placement was favored because of the broad QRS from RV pacing meaning that use of the S-ICD was not possible due to failure of the electrocardiogram to lie within the bounds of the screening template, and the perceived high risk of repeat thoracotomy. We describe the technique for ICD lead placement in a mid-lateral cardiac venous branch of the coronary sinus with the ability to deliver anti-tachycardia pacing and cardiac resynchronization. To our knowledge this is the first report of an ICD in the mid-lateral cardiac vein, with cardiac resynchronization. < This case describes the technique for implantable cardioverter-defibrillator placement in the coronary sinus with biventricular pacing in a patient with a mechanical tricuspid and pre-existing right ventricular endocardial lead. This technique represents a viable alternative to repeat thoracotomy and surgical lead placement, where the risks of complication, prolonged hospital stay and lead failure are high. It also offers the ability to deliver anti-tachycardia pacing and cardiac resynchronization.>.
一名49岁男性因有症状的持续性单形性室性心动过速入院。他既往有与肥厚型心肌病和完全性心脏传导阻滞相关的AMP激酶疾病史,且已植入双腔起搏器。他还因右心室(RV)导线导致三尖瓣损伤引起的严重三尖瓣反流以及二尖瓣上的纤维瘤,进行了机械性三尖瓣置换和二尖瓣置换。他原有的RV导线保留在人工瓣膜环和天然瓣膜环之间。由于存在机械性三尖瓣置换,无法在RV植入植入式心律转复除颤器(ICD),这是一种罕见但具有挑战性的临床情况。手术心外膜导线植入或使用皮下ICD(S-ICD)是可能的替代方案。由于RV起搏导致QRS波增宽,传统的ICD导线植入更受青睐,这意味着由于心电图超出筛查模板范围而无法使用S-ICD,并且认为再次开胸的风险很高。我们描述了在冠状静脉窦的中外侧心脏静脉分支中植入ICD导线的技术,该技术能够进行抗心动过速起搏和心脏再同步治疗。据我们所知,这是首次关于在中外侧心脏静脉中植入具有心脏再同步功能的ICD的报告。<本病例描述了在一名患有机械性三尖瓣且已有右心室心内膜导线的患者中,在冠状静脉窦植入可植入式心律转复除颤器并进行双心室起搏的技术。该技术是再次开胸和手术导线植入的可行替代方案,后者并发症风险高、住院时间长且导线故障率高。它还具备进行抗心动过速起搏和心脏再同步治疗的能力。>